Q
QuantumLeap
DeepTechQuantum-classical hybrid algorithms for pharmaceutical drug discovery.
Stage: Series AYear: 2019Country: GermanyRegion: Europe
DeepTechPharmaQuantumExit
Visit Website$340M
Exit Value
18
Drug Candidates
31
Patents
Company Story
QuantumLeap's proprietary simulation platform accelerates drug discovery from years to weeks. Acquired by a major pharmaceutical group in 2024 for $340M, marking one of Launchpad's most successful exits.